10/18/2024

Janusmed sex and gender

Janusmed sex and gender – Dipyridamole

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
A A
A A

Dipyridamole

Dipyridamole

Class : A

  1. Lowenthal A. Secondary prevention of myocardial infarction in the first European Stroke Prevention Study. Thromb Res Suppl. 1990;12:59-63.
  2. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2 Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143(1):1-13.
  3. Sivenius J, Laakso M, Penttilä IM, Smets P, Lowenthal A, Riekkinen PJ. The European Stroke Prevention Study: results according to sex. Neurology. 1991;41(8):1189-92.
  4. ESPRIT Study Group, Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367:1665-73.
  5. Lökk J. Dipyridamole-associated headache in stroke patients--interindividual differences?. Eur Neurol. 2009;62:109-13.
  6. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2017 [cited 2019-01-30.]